Mode
Text Size
Log in / Sign up

Meta-analysis finds 30.5% breakthrough UTI rate in children with VUR on antibiotic prophylaxisA Scorecard to Spot Kids at Highest Risk of Kidney Infections

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider age, reflux grade, and renal scarring when assessing breakthrough UTI risk in children with VUR on prophylaxis.

This systematic review and meta-analysis pooled data from 24 observational cohort studies involving 3,264 children with vesicoureteral reflux (VUR) who were receiving continuous antibiotic prophylaxis (CAP). The comparator group was not reported. The primary outcome was breakthrough urinary tract infection (BT-UTI). The pooled incidence of BT-UTI was 30.5%. The analysis identified several factors associated with a higher risk of BT-UTI. These included age less than 1 year (OR 2.04), bilateral reflux (OR 1.81), high-grade reflux (grades IV-V, OR 2.65), symptomatic UTI presentation (OR 2.74), a history of recurrent UTI (OR 2.17), bladder and bowel dysfunction (OR 1.81), increased ureteral diameter ratio (mean difference 0.139), and DMSA renal scar formation (OR 4.40). An external validation of a predictive model derived from these factors at a single center (Children's Hospital of Chongqing Medical University, 2021-2024) reported an area under the curve (AUC) of 0.88 (95% CI 0.82-0.93). Safety and tolerability data for CAP were not reported. Key limitations include the observational nature of all included studies, which precludes causal inference, and the lack of a reported comparator group for the main incidence finding. The follow-up duration was also not reported. The external validation was performed at a single center, limiting generalizability. For practice, this analysis quantifies the substantial risk of breakthrough infection despite prophylaxis in this population and identifies a set of clinical and imaging factors associated with that risk. The derived predictive model requires further prospective validation before clinical use.

A tiny problem with big consequences

Vesicoureteral reflux, or VUR, sounds complicated. The idea is simple. Urine that should flow one way, from the bladder down and out, instead flows backward up toward the kidneys.

In kids with VUR, that backflow can carry bacteria upstream. The result is a kidney infection. Repeated kidney infections can leave scars. Scars can damage long-term kidney function.

To prevent this, doctors often prescribe low-dose antibiotics daily, sometimes for years. It is called continuous antibiotic prophylaxis, or CAP.

The catch: it does not always work. Around 3 in 10 children on CAP still get what doctors call a breakthrough urinary tract infection, or BT-UTI.

Picking which kids need the most aggressive care has been guesswork. Some pediatric nephrologists keep children on antibiotics for years out of caution. Others try surgery sooner. Getting the call right matters for kidney health and for avoiding unnecessary antibiotic exposure.

A well-validated risk score could end some of the guesswork. Doctors and families would have a clear tool.

The old way relied on a mix of doctor judgment, family history, and published guidelines. Doctors knew that high-grade reflux, very young age, and past infections all raised risk. But nobody had combined them into one simple score.

This study set out to build that score, based on decades of research combined with a fresh validation in real patients.

How it works, in plain English

Think of risk factors as ingredients in a recipe. Some are pinches of salt. Others are cups of flour. All matter, but not all weigh the same.

A good risk score weighs each ingredient by its actual impact. A child with a tiny pinch of salt is not very different from one without. But a child missing cups of flour is probably baking something different.

The score gives heavier weight to the bigger risk factors and lighter weight to the smaller ones. When added together, the number predicts how likely a breakthrough infection is.

The study snapshot

Researchers first did a meta-analysis. They combined 24 cohort studies covering more than 3,200 children. Out of 26 candidate risk factors they examined, they found 8 that consistently predicted breakthrough UTIs.

Those 8 factors were:

  • Age under 1 year
  • Reflux on both sides (bilateral)
  • High-grade reflux (grades IV to V)
  • Symptomatic UTI history
  • Recurrent UTI history
  • Bladder and bowel dysfunction
  • Wider-than-normal ureter measurement (UDR)
  • Kidney scars visible on scans (DMSA scan)

Each factor was assigned point values. Researchers then tested the score in a separate group of 158 children at a hospital in China.

Here's what they found

The score performed well. At a cutoff of 17 points, it correctly identified most children who would go on to have a breakthrough infection. Sensitivity reached 93 percent, meaning the score rarely missed a future case.

Overall accuracy hit 84 percent. The discrimination score, measured as AUC, reached 0.88, which is considered strong for a clinical risk tool.

The research also checked calibration, which is whether the predicted risk matched actual observed risk. Calibration looked good.

This is where things get interesting.

The score's real value lies in what it lets doctors do with it. High-score children might benefit from tighter follow-up, more aggressive treatment of bowel and bladder dysfunction, or earlier surgical consideration.

Lower-score children could reasonably continue standard care, possibly easing antibiotic use over time.

How the researchers read it

The authors are careful. They say the score is a decision-support tool, not a replacement for clinical judgment. They also note that the external validation was done in a single hospital.

That said, they see real potential. A tool like this could help families understand their child's specific situation in concrete terms, rather than vague statements about "elevated risk."

If your child has VUR and is on preventive antibiotics, talk to your pediatric kidney specialist about risk stratification.

Ask whether any of the eight risk factors apply to your child. If several do, closer monitoring may be worth discussing. If none do, the risk of a breakthrough is probably lower.

Also pay attention to bowel and bladder habits. Constipation and difficulty emptying the bladder are modifiable risk factors. Small changes in routines can help.

The limits

The meta-analysis combined studies of different designs and quality levels. Pooled estimates can hide variations that matter for individual children.

The validation was in one Chinese hospital. Children in different healthcare systems or with different genetic backgrounds may have slightly different risk patterns.

The score also does not predict which kids on CAP will develop long-term kidney damage. It predicts infection risk, which is related but not identical.

Larger, multi-center validation studies would help confirm the score's performance. Researchers also want to test whether using the score changes real outcomes, not just predicts risk.

Eventually, tools like this could be embedded into electronic medical records. Your doctor might see a personalized risk score without any extra work.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Breakthrough urinary tract infection (BT-UTI) among children with vesicoureteral reflux (VUR) receiving continuous antibiotic prophylaxis (CAP) remains a clinical challenge with heterogeneous risk profiles and no validated prediction tools. We aimed to identify robust risk factors and develop an evidence-based predictive score for BT-UTI. METHODS: We conducted a systematic review and meta-analysis following PRISMA and Cochrane guidance, searching PubMed, Web of Science, and Embase for cohort studies. Pooled effect estimates were calculated using appropriate fixed- or random-effects models; a scoring system was derived by natural logarithm transformation of pooled estimates. External validation used a cohort of 158 children with VUR receiving CAP at Children's Hospital of Chongqing Medical University (2021-2024). RESULTS: Twenty-four cohort studies (n = 3,264) were included; pooled BT-UTI incidence was 30.5%. From 26 candidate factors, eight stable predictors were retained and incorporated into the score: age < 1 year (OR 2.04), bilateral reflux (OR 1.81), high-grade reflux IV-V (OR 2.65), symptomatic UTI (OR 2.74), history of recurrent UTI (OR 2.17), bladder and bowel dysfunction (BBD; OR 1.81), increased ureteral diameter ratio (UDR; MD 0.139), and DMSA renal scar formation (OR 4.40). External validation showed AUC 0.88 (95% CI 0.82-0.93); at a cutoff of 17 points accuracy was 0.84, and sensitivity 0.93. Calibration and decision-curve analyses indicated good agreement and a positive net clinical benefit. CONCLUSIONS: We developed and externally validated an eight-item BT-UTI risk score for children with VUR on CAP that demonstrates high discrimination and clinical utility for individualized risk stratification and prevention planning and implementation guidance available.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.